UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$552M |
| 2 |
Microsoft
MSFT
|
+$336M |
| 3 |
Accenture
ACN
|
+$230M |
| 4 |
Walmart Inc
WMT
|
+$206M |
| 5 |
Mastercard
MA
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$329M |
| 2 |
CELG
Celgene Corp
CELG
|
+$293M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$220M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$181M |
| 5 |
JPMorgan Chase
JPM
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.8% |
| 2 | Financials | 14.05% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCH
1726
Dauch Corp
DCH
$1.42B
| $1.32M | ﹤0.01% |
122,476
-17,213
| -12% | -$164K |
|
|
AMWD
1727
DELISTED
American Woodmark
AMWD
| $1.32M | ﹤0.01% |
12,599
+1,742
| +16% | +$175K |
|
|
ENLC
1728
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $1.31M | ﹤0.01% |
214,467
+990
| +0.5% | +$6.01K |
|
|
SAFE
1729
Safehold
SAFE
$1.16B
| $1.31M | ﹤0.01% |
18,609
-2,096
| -10% | -$133K |
|
|
KNL
1730
DELISTED
Knoll, Inc.
KNL
| $1.31M | ﹤0.01% |
51,717
+4,185
| +9% | +$111K |
|
|
BEAT
1731
DELISTED
BioTelemetry, Inc.
BEAT
| $1.31M | ﹤0.01% |
28,192
-2,767
| -9% | -$120K |
|
|
EGOV
1732
DELISTED
NIC Inc
EGOV
| $1.3M | ﹤0.01% |
58,175
+8,864
| +18% | +$194K |
|
|
NP
1733
DELISTED
Neenah, Inc. Common Stock
NP
| $1.3M | ﹤0.01% |
18,441
+44
| +0.2% | +$2.99K |
|
|
BRKL
1734
DELISTED
Brookline Bancorp
BRKL
| $1.3M | ﹤0.01% |
78,894
-17,165
| -18% | -$271K |
|
1735
Safety Insurance
SAFT
$1.52B
| $1.3M | ﹤0.01% |
14,003
+2,154
| +18% | +$210K |
|
1736
DNOW Inc
DNOW
$2.63B
| $1.3M | ﹤0.01% |
115,218
+2,278
| +2% | +$25.4K |
|
1737
Schneider National
SNDR
$6.37B
| $1.29M | ﹤0.01% |
59,050
+22,981
| +64% | +$517K |
|
1738
Medifast
MED
$145M
| $1.29M | ﹤0.01% |
11,727
-1,621
| -12% | -$157K |
|
|
DRNA
1739
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.28M | ﹤0.01% |
58,283
+8,372
| +17% | +$168K |
|
1740
Interparfums
IPAR
$4.12B
| $1.28M | ﹤0.01% |
17,652
-534
| -3% | -$38.9K |
|
1741
Avantor
AVTR
$9.25B
| $1.28M | ﹤0.01% |
70,706
+12,803
| +22% | +$204K |
|
1742
HUB Group
HUBG
$2.92B
| $1.28M | ﹤0.01% |
49,970
-204
| -0.4% | -$5.04K |
|
1743
Gentherm
THRM
$1.32B
| $1.28M | ﹤0.01% |
28,866
+569
| +2% | +$24.2K |
|
1744
Central Garden & Pet Co Class A
CENTA
$2.42B
| $1.28M | ﹤0.01% |
54,500
-16,735
| -23% | -$376K |
|
|
NTUS
1745
DELISTED
Natus Medical Inc
NTUS
| $1.27M | ﹤0.01% |
38,553
+21
| +0.1% | +$673 |
|
1746
Materion
MTRN
$4.72B
| $1.27M | ﹤0.01% |
21,347
-28
| -0.1% | -$1.66K |
|
|
GES
1747
DELISTED
Guess Inc
GES
| $1.26M | ﹤0.01% |
56,495
-587
| -1% | -$10.9K |
|
|
DMC
1748
Del Monte Corp
DMC
$1.41B
| $1.26M | ﹤0.01% |
36,097
+2,247
| +7% | +$71.9K |
|
|
ESPR
1749
DELISTED
Esperion Therapeutics
ESPR
| $1.26M | ﹤0.01% |
21,170
+88
| +0.4% | +$3.96K |
|
1750
Kodiak Sciences
KOD
$2.68B
| $1.26M | ﹤0.01% |
+17,540
| New | +$638K |
|
Similar funds
UBS AM's Q4 2019 Portfolio in Review
As of Q4 2019, UBS AM held 2,974 positions worth $163B, up 10% from $148B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q4 2019 filing shows 83 new, 1,539 increased, 805 reduced and 441 closed positions. Its largest new stake was Pinterest: 348,973 shares worth $6.5M. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $329M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q4 2019 buy was Pinterest: 348,973 shares worth $6.5M.
- UBS AM added most to Alibaba in Q4 2019, an estimated $552M increase.
- UBS AM's biggest Q4 2019 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $181M.
- UBS AM fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2019, selling an estimated $329M.
- UBS AM's ten largest holdings make up 21% of its $163B portfolio in Q4 2019.
- UBS AM opened 83 new positions and closed 441 in Q4 2019.
- UBS AM's portfolio value rose 10% quarter-over-quarter to $163B.
Based on UBS AM's 13F filing for Q4 2019, filed 14 Feb 2020.